Also listed on Athenex, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Collateral for a security interest recorded Sep 16, 2022 (Sagard Healthcare Royalty Partners, LP).
Term ends Feb 2, 2029 · High confidence
20-year base term ends Dec 28, 2027
Held by Atnx SPV, LLC
Filed Dec 28, 2007 as application 12/005,792 · Granted Dec 14, 2010
Base term plus 402 days of patent term adjustment (USPTO delay)
Today
2007
2029
Clock starts
Dec 28, 2007
Dec 28, 2007
Term ends
Feb 2, 2029
Feb 2, 2029
Granted
Dec 14, 2010
Dec 14, 2010
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
402
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 402 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 28, 2007, when this application, 12/005,792, was filed | Dec 28, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +402 days, USPTO patent term adjustment record | Feb 2, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 2, 2029 | High confidence |
This family
| US 7,851,470 | this patent Feb 2029 | Feb 2029 |
| US 7,939,529 | In force Jan 2029 | Jan 2029 |
| US 7,935,697 | In force Dec 2027 | Dec 2027 |
| US 8,309,549 | In force no later than Dec 2027 | no later than Dec 2027 |
| US 8,293,739 | In force no later than Dec 2027 | no later than Dec 2027 |
| US 8,901,297 | In force Dec 2027 | Dec 2027 |
| US 9,556,120 | In force Jan 2028 | Jan 2028 |
| US 10,323,001 | In force Dec 2027 | Dec 2027 |
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 16, 2008 Reel 20956, frame 795 | Hangauer, David G., JR.; Coughlin, Daniel; Cody, Jeremy A.; Gale, Jonathan | Kinex Pharmaceuticals, LLC | Assignment of Assignor's Interest |
| Jul 7, 2009 Reel 22920, frame 524 | Patra, Debasis | Kinex Pharmaceuticals, LLC | Assignment of Assignor's Interest |
| Jul 14, 2009 Reel 22950, frame 363 | Patra, Debasis | Kinex Pharmaceuticals, LLC | Corrective Assignment to Correct the Assignee Address to 701 Ellicott Street, Ny Center for Excellence in Bioinformatics and Life Sciences, Buffalo, Ny 14203 Previously Recorded on Reel 022920 Frame 0524. Assignor(S) Hereby Confirms the Debasis Patra to Kinex Pharmaceuticals, LLC. |
| Sep 10, 2015 Reel 36585, frame 786 | Kinex Pharmaceuticals, LLC | Kinex Pharmaceuticals, Inc. | Change of Name |
| Sep 21, 2015 Reel 36644, frame 296 | Kinex Pharmaceuticals, Inc. | Athenex, Inc. | Change of Name |
| Jul 3, 2018 Reel 47247, frame 812 | Athenex, Inc. | Perceptive Credit Holdings II, LP | Patent Security Agreement |
| Jun 19, 2020 Reel 52990, frame 677 | Perceptive Credit Holdings II, LP | Athenex, Inc. | Release of Security Interest |
| Jun 22, 2020 Reel 53005, frame 657 | Athenex, Inc. | Oaktree Fund Administration, LLC | Security Interest |
| Sep 13, 2022 Reel 61071, frame 86 | Athenex, Inc. | Atnx SPV, LLC | Assignment of Assignor's Interest |
| Sep 16, 2022 Reel 61119, frame 681 | Athenex, Inc. | Sagard Healthcare Royalty Partners, LP, as Administrative Agent | Security Interest |
| Sep 16, 2022 Reel 61119, frame 920 | Atnx SPV, LLC | Sagard Healthcare Royalty Partners, LP, as Administrative Agent | Security Interest |
| Jul 27, 2026 Reel 76534, frame 576 | Atnx SPV, LLC | Atnx SPV, LLC | Assignee Change of Address |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Feb 2029
Term ends Feb 2, 2029. No further fees fall due before then
Note
The 402 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
26
later US patents cite this one
That is above the median of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.